nbsp; transforming growth factor beta-1: its type II receptor and Smad signaling pathway correlate with inflammation and
fibrosis in chronic liver disease of viral etiology. J Gastroenterol Hepatol 2003;18:1302-1308
23 宋仕玲, 龚作炯, 张全荣. 实验性大鼠肝纤维化TGFbeta1及其受体mRNA与Smad3,7的表达. 世界华人消化杂志
2004;12:676-679
24 Matsuzaki K, Date M, Furukawa F, Tahashi Y, Matsushita M, Sugano Y, Yamashiki N, Nakagawa T, Seki T, Nishizawa M,
Fujisawa J, Inoue K. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human
hepatocellular carcinoma: implications for roles of smads in its growth. Hepatology 2000;32:218-227
25 Park do Y, Lee CH, Sol MY, Suh KS, Yoon SY, Kim JW. Expression and localization of the transforming growth factor-beta
type I receptor and Smads in preneoplastic lesions during chemical hepatocarcinogenesis in rats. J Korean Med Sci
2003;18:510-519
26 Yakicier MC, Irmak MB, Romano A, Kew M, Ozturk M. Smad2 and Smad4 gene mutations in hepatocellular
carcinoma.Oncogene 1999;18:4879-4883
27 Teicher BA. Malignant cells, directors of the malignant process: role of transforming growth factor-beta. Cancer
M << 上一页 [11] [12] [13] [14] [15] [16] [17] [18] [19] 下一页
|
